The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Review the latest news and information on the COVID-19 Pandemic.
read more
Tuesday, October 13, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Tuesday, October 20, 2020
The FDA is clarifying the intent of the November 2019 revisions to labeling for insulin pens.
read more
The FDA has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older for COVID-19 requiring ...
read more
Thursday, November 05, 2020
Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and commercialize DARPin program.
read more
Tuesday, November 10, 2020
Pfizer and BioNTech announced their vaccine candidate against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants ...
read more
Tuesday, November 10, 2020
The FDA granted EUA for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab.
read more
Tuesday, November 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Monday, November 16, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Thursday, November 19, 2020
Ypsomed is advancing its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT and Lonza.
read more
Thursday, November 19, 2020
Amgen Inc., AstraZeneca Pharmaceuticals
Amgen and AstraZeneca announced positive topline results from the Phase 3 trial in which the investigational medicine tezepelumab demonstrated a ...
read more
Monday, November 23, 2020
Pfizer and BioNTech will submit a request to the FDA for EUA of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2.
read more
Monday, November 23, 2020
Regeneron announced the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19,...
read more
Monday, November 23, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Friday, December 11, 2020
Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the FDA has informed the sponsor ...
read more